Molecular_JJ
regulation_NN
of_IN
cytokine_NN
gene_NN
expression_NN
during_IN
the_DT
immune_JJ
response_NN
._.

Cytokine_NN
expression_NN
by_IN
immune_JJ
system_NN
cells_NNS
plays_VBZ
an_DT
important_JJ
role_NN
in_IN
the_DT
regulation_NN
of_IN
the_DT
immune_JJ
response_NN
._.

On_IN
first_JJ
encounter_NN
with_IN
antigen_NN
,_,
naive_JJ
CD4_NN
+_CC
T_NN
helper_NN
-LRB-_-LRB-
Th_NN
-RRB-_-RRB-
cells_NNS
differentiate_VBP
into_IN
cytokine-producing_JJ
effector_NN
cells_NNS
._.

Two_CD
types_NNS
of_IN
effector_NN
cells_NNS
characterized_VBN
by_IN
their_PRP$
distinct_JJ
expression_NN
of_IN
cytokine_NN
profiles_NNS
have_VBP
been_VBN
described_VBN
._.

Th1_NN
cells_NNS
produce_VBP
IL-2_NN
and_CC
IFN-gamma_NN
,_,
whereas_IN
Th2_NN
cells_NNS
produce_VBP
IL-4_NN
,_,
IL-5_NN
,_,
IL-6_NN
,_,
IL-10_NN
,_,
and_CC
IL-13_NN
._.

In_IN
many_JJ
pathological_JJ
situations_NNS
,_,
the_DT
balance_NN
between_IN
Th1_NN
and_CC
Th2_NN
immune_JJ
responses_NNS
determines_VBZ
the_DT
outcome_NN
of_IN
diverse_JJ
immunologically_RB
mediated_VBN
clinical_JJ
syndromes_NNS
including_VBG
infectious_JJ
,_,
autoimmune_JJ
,_,
and_CC
allergic_JJ
diseases_NNS
._.

However_RB
,_,
the_DT
molecular_JJ
basis_NN
for_IN
the_DT
tissue-specific_JJ
expression_NN
of_IN
Th1\/Th2-like_JJ
cytokines_NNS
has_VBZ
remained_VBN
elusive_JJ
._.

In_IN
this_DT
review_NN
we_PRP
evaluate_VBP
the_DT
possible_JJ
in_FW
vivo_FW
role_NN
of_IN
different_JJ
transcription_NN
factors_NNS
and_CC
transcriptional_JJ
mechanisms_NNS
in_IN
T_NN
cell_NN
differentiation_NN
and_CC
the_DT
immune_JJ
response_NN
._.

